This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
CASI Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00658671
First received: April 11, 2008
Last updated: January 26, 2016
Last verified: January 2016